HOUSTON, Nov. 13, 2012 /PRNewswire/ -- Cyberonics, Inc. (CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 11:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on November 27, 2012. No slides will be presented at the conference. About Cyberonics, Inc. and the VNS Therapy System Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide. Additional information on Cyberonics and the VNS Therapy System is available at http://www.cyberonics.com. Contact Information Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 ir@cyberonics.com Original post: Cyberonics To … Continue reading →

BULLHEAD CITY For many people living with epilepsy, it can take a toll on their life, even stopping it in right in its tracks. For Bullhead City resident Jeanne Phelps, living with the disorder can become a teaching tool for others when it comes to spreading the word about epilepsy, and that is exactly what Phelps has done. Phelps has begun incorporating medical information and social media to help spread the word about the disorder during Epilepsy Awareness Month, which is recognized nationwide in November. I was 27 years old when I was finally diagnosed, but I think I have had the disorder since I was a child, said Phelps. Phelps had her first known seizure in 1976 while in the U.S. Air Force. During a routine warm-up she had a convulsion, blacked out and woke up in a hospital room. With a medical discharge from the Air Force and an unknown disorder, Phelps future was up in the air. I didnt know what to do or where to go from there, she said. When I finally finished the medicine a month later and was no longer having episodes, I thought to myself I was finally cured. I was wrong. … Continue reading →

Two to three times a day, Naomi Lewkowski, a 23-year-old stay-at-home mom, would have a seizure. Shed pass out, part of her body might twitch or shed have trouble breathing. Sometimes shed injure herself on the fall and often she was rushed to the hospital. Her son, who was just a baby at the time, would sit there for the two to three minutes that his mom was unconscious. Lewkowski tried several of the anti-seizure medications, but none of them helped, or the side effects were too extreme. So, Lewkowski and her husband hired an around-the-clock caregiver to help care for herself and their son. But recently, Lewkowski learned about an epilepsy treatment that was like a pacemaker for the brain. Called vagus nerve stimulation (VNS) therapy, the device is implanted in the chest and sends rhythmic impulses to the vagus nerve in the neck, which in turn sends impulses to the brain. Just like the heart has a beat, the brain has a beat, said Dr. Blanca Vazquez-Santana, of the Comprehensive Epilepsy Center of New York University Langone Medical Center. Epilepsy occurs when there are abnormal electrical discharges of the brain. VNS can get the beat back to normal." … Continue reading →

12 November 2012 Last updated at 12:11 ET By James Gallagher Health and science reporter, BBC News Adding "calm down" genes to hyperactive brain cells has completely cured rats of epilepsy for the first time, say UK researchers. They believe their approach could help people who cannot control their seizures with drugs. The study, published in the journal Science Translation Medicine, used a virus to insert the new genes into a small number of neurons. About 50 million people have epilepsy worldwide. However, drugs do not work for up to 30% of them. The alternatives include surgery to remove the part of the brain that triggers a fit or to use electrical stimulation. The brain is alive with electrical communication with individual neurons primed to fire off new messages. However, if a group of neurons become too excited they can throw the whole system into chaos leading to an epileptic seizure. Researchers at University College London have developed two ways of manipulating the behaviour of individual cells inside the brain in order to prevent those seizures. Both use viruses injected into the brain to add tiny sections of DNA to the genetic code of just a few thousand neurons. One … Continue reading →

Pediatric Rehabilitation And Behavioral Services San Antonio TX Pediatric Rehabilitation And Behavioral Services San Antonio TX local.mysanantonio.com autism treatment, developmental delay, outpatient pediatric services, feeding therapy in children, special needs services, behavior therapy, sensory integration, pediatric occupational therapy,speech therapy, ABA therapy,From:mySAListViews:0 0ratingsTime:00:57More inPeople Blogs See the article here: Pediatric Rehabilitation And Behavioral Services San Antonio TX - Video … Continue reading →

Published: Nov. 13, 2012 at 11:22 PM PHOENIX, Nov. 13 (UPI) -- Metal-binding agent 2,3-Dimercaptopropane-1-sulfonate, prescribed by some alternative practitioners to treat autism, does not work, U.S. researchers say. Jennifer Cohen and Michelle Ruha of the Banner Good Samaritan Medical Center in Phoenix said metal-binding agents such as DMPS have received significant attention amid the controversy over the alleged link between mercury and autism. Even though no causal relationship between mercury in vaccines and autism has been proven, some practitioners treat their patients with mercury-binding agents in an effort to help the body eliminate mercury and treat autism. One of these agents is a formulation of DMPS applied to the skin, which is approved in Europe for the treatment of heavy metal toxicity, but is not approved by the United States, but it can be purchased on the Internet. Cohen and the research team looked at whether topically applied DMPS is absorbed into the body by measuring levels in the blood 30, 60, 90, 120, and 240 minutes after application. They also measured whether DMPS applied to the skin resulted in an increased excretion of mercury in the urine 12 and 24 hours after application. The study comprised eight healthy … Continue reading →

Public release date: 13-Nov-2012 [ | E-mail | Share ] Contact: Joan Robinson joan.robinson@springer.com 49-622-148-78130 Springer Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism. Their work is published online in Springer's Journal of Medical Toxicology. Metal-binding agents such as DMPS* have received significant attention in recent decades amid the controversy over the link between mercury and autism. Even though no causal relationship between mercury in vaccines and autism has been proven, some practitioners treat their patients with mercury-binding agents in an effort to help the body eliminate mercury and treat the autism. One of these agents is a formulation of DMPS which is applied to the skin, also known as topical application. DMPS is approved in Europe for the treatment of heavy metal toxicity, but is not approved by the US FDA for use in the USA. For the first time, Cohen and … Continue reading →